Article
In vivo screening of haloalkane dehalogenase mutants.
Bioorganic & medicinal chemistry - 1 Oct 1999
Chang C H, Schindler J F, Unkefer C J, Vanderberg L A, Brainard J R, Terwilliger T C
Abstract excerpt
Haloalkane dehalogenase (Dh1A) from Xanthobacter autotrophicus GJ10 catalyzes the dehalogenation of short chain primary alkyl halides. Due to the high Km and low turnover, wild type Dh1A is not optimal for applications in bioremediation. We have developed an in vivo screen, based on a colorimetric pH indicator, to identify Dh1A mutant with improved catalytic activity. After screening 50,000 colonies, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
